doc. MUDr. Alexandr Poprach, Ph.D.
Associate professor, Comprehensive Cancer Care Department
Total number of publications: 137
2022
-
Biomarker Dynamics and Long-Term Treatment Outcomes in Breast Cancer Patients with Residual Cancer Burden after Neoadjuvant Therapy
Diagnostics, year: 2022, volume: 12, edition: 7, DOI
-
DIA-MS identifies proteins associated with a poor response of metastatic renal cell carcinoma to tyrosine kinase inhibitor treatment
Year: 2022, type: Conference abstract
-
LncRNA PVT1 is increased in renal cell carcinoma and affects viability and migration in vitro
JOURNAL OF CLINICAL LABORATORY ANALYSIS, year: 2022, volume: 36, edition: 6, DOI
-
Oncological outcomes of surgery for isolated retroperitoneal recurrence in renal cancer patients after radical nephrectomy
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, year: 2022, volume: 40, edition: 3, DOI
-
Patients with metastatic renal cell carcinoma treated with cabozantinib in the Czech Republic: analysis of four cancer centers
Biomedical Papers, Olomouc: Palacky University, year: 2022, volume: 166, edition: 1, DOI
-
Proteiny odpovědné za špatnou terapeutickou odpověď metastatických nádorů ledvin na léčbu tyrosinkinasovými inhibitory
Year: 2022, type: Conference abstract
-
Proteotype classification of renal cell carcinoma for prognosis and therapy response
Year: 2022, type: Conference abstract
2021
-
A large-scale assay library for targeted protein quantification in renal cell carcinoma tissues
Year: 2021, type: Conference abstract
-
Administration of Nivolumab in Metastatic Renal Cell Cancer Following Treatment With mTOR Inhibitors
In vivo, year: 2021, volume: 35, edition: 5, DOI
-
Clinical Results and Biomarker Analyses of Axitinib and TRC105 versus Axitinib Alone in Patients with Advanced or Metastatic Renal Cell Carcinoma (TRAXAR)
ONCOLOGIST, year: 2021, volume: 26, edition: 7, DOI